Aventis and ImmunoGen Enter Anticancer Antibody Collaboration
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 39 (Table of Contents)
Published: 1 Aug-2003
DOI: 10.3833/pdr.v2003.i39.867 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Aventis and ImmunoGen entered into a collaboration agreement to discover, develop and commercialize antibody-based anticancer drugs...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS